Corpus Intelligence IC Memo — D W MCMILLAN MEMORIAL HOSPITAL 2026-04-26 09:04 UTC
IC Memo — D W MCMILLAN MEMORIAL HOSPITAL
Investment Committee Memorandum | AL | 46 beds | Grade D | EBITDA uplift $2.3M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

D W MCMILLAN MEMORIAL HOSPITAL

CCN 010099 | ESCAMBIA, AL | 46 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

D W MCMILLAN MEMORIAL HOSPITAL is a 46-bed under-performing / distressed in ESCAMBIA, AL with $30.8M in net patient revenue and a -24.6% operating margin. The hospital serves a payer mix of 27.2% Medicare, 19.3% Medicaid, and 53.5% commercial.

Thesis: Turnaround. Our ML models identify $2.3M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -24.6% to -17.2% (+736bps).

Net Revenue HCRIS$30.8M
Current EBITDA COMPUTED$-7.6M
Operating Margin COMPUTED-24.6%
Occupancy HCRIS25.7%
Revenue / Bed COMPUTED$669K
Net-to-Gross HCRIS22.6%
Distress Probability ML57.3%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
58
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -24.6% places it below the state median. Among 58 size-comparable peers (23-92 beds), the median margin is -15.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (23-92), prioritizing same-state peers. 58 hospitals in the comp set.

HospitalStateBedsRevenueMargin
D W MCMILLAN MEMORIAL HOSPITAL (Target)AL46$30.8M-24.6%
ATHENS LIMESTONEAL66$88.9M-20.9%
RUSSELL MEDICAL CENTERAL45$75.3M-14.8%
JACK HUGHSTON MEMORIAL HOSPITAAL47$75.2M6.5%
EASTPOINTE HOSPITALAL66$56.6M-50.0%
NORTH BALDWIN INFIRMARYAL35$55.3M-3.3%
PRATTVILLE BAPTIST HOSPITALAL55$53.5M-16.2%
HIGHLANDS MEDICAL CENTERAL45$45.9M-30.2%
ENCOMPASS HEALTH REHABILITATIOAL85$42.1M17.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.3M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$646K+210bp18mo
Cost to Collect4.5%2.5%$615K+200bp12mo
Denial Rate Reduction12.0%6.5%$609K+198bp12mo
A/R Days Reduction5200.0%3800.0%$374K+122bp9mo
Clean Claim Rate88.0%96.0%$20K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$646K
Cost to Collect
$615K
Denial Rate Reduction
$609K
A/R Days Reduction
$374K
Clean Claim Rate
$20K
Total EBITDA Uplift$2.3M
Current EBITDA$-7.6M
+ RCM Uplift+$2.3M
Pro Forma EBITDA$-5.3M
Current Margin-24.6%
Pro Forma Margin-17.2%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-11.6M$-27.2M0.00x-100.0%
Base (11x exit)10.0x11.0x$-11.6M$-33.7M0.00x-100.0%
Bull Case9.0x11.0x$-10.5M$-30.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.5M$-35.8M0.00x-100.0%
Bear Case11.0x10.0x$-12.8M$-34.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-12.8M$-42.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 25.7%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 58 hospitals with 23-92 beds
  • Same-state prioritization (n=59)
  • Comp margins: P25=-26.6% / P50=-15.3% / P75=1.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.